NCT00122915View on ClinicalTrials.gov

CONCEPT: Crossover Efficacy Pain Trial in Motor Cortex Stimulation for Intractable Neuropathic Pain

PHASE3TerminatedINTERVENTIONAL
Enrollment

104

Participants

Timeline

Start Date

June 30, 2005

Primary Completion Date

March 31, 2008

Study Completion Date

March 31, 2008

Conditions
Pain, IntractableFacial Pain
Interventions
DEVICE

Cortical lead, 8 electrodes (Model 2976) with Synergy neurostimulator

Trial Locations (11)

1070

Hopital Erasme, Service de Neurochirurgie, Brussels

1200

UCL St luc, Neurochirurgie, Brussels

3000

UZ Gasthuisberg , Department of Neurosurgery, Leuven

4000

CH de la Citadelle, Liège

6020

Universitätsklinik Innsbruck, Universitätsklinik für Neurochirurgie, Innsbruck

9000

AZ St Lucas, Neurochirugie, Ghent

9100

Maria Middelares ZH, Saint Niklaas

23538

Universitätsklinikum Schleswig-Holstein, Campus Lübeck, Lübeck

28007

Hospital Gregorio Maranon, Servicio de Neurologia, Madrid

35043

Klinikum der Philipps-Universität Marburg, Marburg

08025

Santa Creu I Sant Pau, Servicio de Neurocirugia, Barcelona

Sponsors

Lead Sponsor

MedtronicNeuro
All Listed Sponsors
lead

MedtronicNeuro

INDUSTRY

NCT00122915 - CONCEPT: Crossover Efficacy Pain Trial in Motor Cortex Stimulation for Intractable Neuropathic Pain | Biotech Hunter | Biotech Hunter